We are live on !
Find out more
Curi Wealth Management Portfolio holdings
AUM
$724M
Turnover
16.47%
1-Year Est. Return
17.43%
This Fund
S&P 500
This Quarter Est. Return
-12.86%
1 Year Est. Return
+17.43%
3 Year Est. Return
+16.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$520M
AUM Growth
-$58.1M
(-10%)
Cap. Flow
+$21.5M
Cap. Flow % of AUM
Cap. Flow %
4.14%
Top 10 Holdings %
Top 10 Hldgs %
38.91%
Holding
753
New
97
Increased
248
Reduced
73
Closed
22
Avg Time Held
Equity + Options
0.5
years
Top 10 Avg Time Held
Equity + Options
0.7
years
Top 20 Avg Time Held
Equity + Options
0.7
years
Avg Time Held Equity only
0.5
years
Top 10 Avg Time Held Equity only
0.7
years
Top 20 Avg Time Held Equity only
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.81M |
| 2 |
Charles River Laboratories
CRL
|
+$3.94M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$3.59M |
| 4 |
iShares AAA-A Rated Corporate Bond ETF
QLTA
|
+$2.1M |
| 5 |
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
|
+$1.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$8.06M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$6.59M |
| 3 |
Walt Disney
DIS
|
+$6.17M |
| 4 |
Ball Corp
BALL
|
+$1.4M |
| 5 |
Applied Materials
AMAT
|
+$646K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.82% |
| 2 | Healthcare | 19.5% |
| 3 | Technology | 12.26% |
| 4 | Financials | 9.06% |
| 5 | Consumer Discretionary | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Schwab US Large- Cap ETF
SCHX
$73.7B
| $41.2M | 7.94% |
2,770,923
+221,553
| +9% | +$3.59M |
2020 Q4
6 quarters
|
|
|
2
iShares Core S&P 500 ETF
IVV
$880B
| $37.9M | 7.29% |
99,885
+14,116
| +16% | +$5.81M |
2020 Q4
6 quarters
|
|
3
UnitedHealth
UNH
$360B
| $19.8M | 3.8% |
38,456
+480
| +1% | +$241K |
2020 Q4
6 quarters
|
|
|
4
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
| $16.6M | 3.2% |
343,106
+36,567
| +12% | +$1.78M |
2020 Q4
6 quarters
|
|
5
Microsoft
MSFT
$3.93T
| $16.4M | 3.15% |
63,794
+1,939
| +3% | +$526K |
2020 Q4
6 quarters
|
|
6
IQVIA
IQV
$43.9B
| $14.4M | 2.78% |
66,524
+1,057
| +2% | +$230K |
2021 Q4
2 quarters
|
|
7
Alphabet (Google) Class C
GOOG
$4.12T
| $14.4M | 2.76% |
131,240
-1,880
| -1% | -$222K |
2020 Q4
6 quarters
|
|
|
8
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.18B
| $14.1M | 2.71% |
291,222
+42,660
| +17% | +$2.1M |
2020 Q4
6 quarters
|
|
9
Schwab US Mid-Cap ETF
SCHM
$14.4B
| $13.7M | 2.64% |
656,172
+65,706
| +11% | +$1.52M |
2020 Q4
6 quarters
|
|
10
Northrop Grumman
NOC
$73.9B
| $13.7M | 2.63% |
28,604
+48
| +0.2% | +$22K |
2021 Q4
2 quarters
|
|
11
Mastercard
MA
$541B
| $13.4M | 2.58% |
42,482
+892
| +2% | +$307K |
2021 Q4
2 quarters
|
|
12
JPMorgan Chase
JPM
$902B
| $12.9M | 2.48% |
114,368
+2,012
| +2% | +$249K |
2020 Q4
6 quarters
|
|
13
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $12.8M | 2.46% |
282,190
+31,970
| +13% | +$1.58M |
2020 Q4
6 quarters
|
|
14
Maravai LifeSciences
MRVI
$1.01B
| $12.2M | 2.35% |
430,451
+10,005
| +2% | +$317K |
2022 Q1
1 quarter
|
|
15
Visa
V
$756B
| $12.2M | 2.35% |
61,888
-31
| -0.1% | -$6.41K |
2020 Q4
6 quarters
|
|
|
16
Applied Materials
AMAT
$325B
| $11M | 2.11% |
120,562
-5,890
| -5% | -$646K |
2021 Q4
2 quarters
|
|
17
Thermo Fisher Scientific
TMO
$255B
| $10.9M | 2.1% |
20,100
+25
| +0.1% | +$13.8K |
2021 Q4
2 quarters
|
|
18
Microchip Technology
MCHP
$40.1B
| $10.7M | 2.06% |
184,006
-647
| -0.4% | -$42.8K |
2021 Q4
2 quarters
|
|
19
Merck
MRK
$360B
| $10.5M | 2.02% |
114,844
+244
| +0.2% | +$21.6K |
2021 Q4
2 quarters
|
|
20
Invesco Aerospace & Defense ETF
PPA
$7.61B
| $9.8M | 1.89% |
140,128
+15,411
| +12% | +$1.12M |
2022 Q1
1 quarter
|
|
21
Abbott
ABT
$181B
| $9.8M | 1.88% |
90,095
+728
| +0.8% | +$82.7K |
2021 Q4
2 quarters
|
|
22
iShares Core MSCI EAFE ETF
IEFA
$190B
| $9.6M | 1.86% |
163,900
+15,322
| +10% | +$983K |
2020 Q4
6 quarters
|
|
23
Danaher
DHR
$161B
| $9.5M | 1.84% |
42,438
+5,788
| +16% | +$1.33M |
2020 Q4
6 quarters
|
|
24
Schwab International Equity ETF
SCHF
$66.8B
| $9.27M | 1.78% |
589,700
+59,972
| +11% | +$1.02M |
2020 Q4
6 quarters
|
|
|
25
Charles River Laboratories
CRL
$14.3B
| $8.65M | 1.66% |
40,416
+16,104
| +66% | +$3.94M |
2022 Q1
1 quarter
|
|
Similar funds
RCG
SGCIA
Curi Wealth Management's Q2 2022 Portfolio in Review
As of Q2 2022, Curi Wealth Management held 753 positions worth $520M, down 10% from $578M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Curi Wealth Management deployed $21.5M of net new capital in Q2 2022, opening 97 new positions and adding to 248 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 26,196 shares worth $828K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 44% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Mondelez International, an estimated $8.06M trimmed.
- Curi Wealth Management's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 26,196 shares worth $828K.
- Curi Wealth Management added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $5.81M increase.
- Curi Wealth Management's biggest Q2 2022 reduction was Mondelez International, cutting an estimated $8.06M.
- Curi Wealth Management fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $464K.
- Curi Wealth Management's ten largest holdings make up 39% of its $520M portfolio in Q2 2022.
- Curi Wealth Management opened 97 new positions and closed 22 in Q2 2022.
- Curi Wealth Management's portfolio value fell 10% quarter-over-quarter to $520M.
Based on Curi Wealth Management's 13F filing for Q2 2022, filed 8 Aug 2022.